Founded Year
2001Stage
Series A | AliveTotal Raised
$4.99MLast Raised
$4.99M | 17 yrs agoAbout ReceptIcon
Developer of kidney receptor antagonists. The company develops antagonists designed to prevent the accumulation of therapeutics in the kidney, which can be used as active pharmaceutical ingredients (APIs) for the reformulation of nephrotoxic drugs without toxic side effects.
ReceptIcon Headquarters Location
Gustav Wieds Vej 10 Aarhus C
Copenhagen, 8000,
Denmark
45 86 20 51 94
Expert Collections containing ReceptIcon
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
ReceptIcon is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
When was ReceptIcon founded?
ReceptIcon was founded in 2001.
Where is ReceptIcon's headquarters?
ReceptIcon's headquarters is located at Gustav Wieds Vej 10, Copenhagen.
What is ReceptIcon's latest funding round?
ReceptIcon's latest funding round is Series A.
How much did ReceptIcon raise?
ReceptIcon raised a total of $4.99M.
Who are the investors of ReceptIcon?
Investors of ReceptIcon include Dansk Erhvervsinvestering, Ostjysk Innovation and Vecata.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.